tiprankstipranks
Torii Pharmaceutical Co (TRXPF)
:TRXPF
Holding TRXPF?
Track your performance easily

Torii Pharmaceutical Co (TRXPF) Stock Price & Analysis

4 Followers

TRXPF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.64%96.97%
Insiders
― Other Institutional Investors
96.97% Public Companies and
Individual Investors

TRXPF FAQ

What was Torii Pharmaceutical Co ’s price range in the past 12 months?
Torii Pharmaceutical Co lowest stock price was $19.82 and its highest was $34.25 in the past 12 months.
    What is Torii Pharmaceutical Co ’s market cap?
    Torii Pharmaceutical Co ’s market cap is $823.21M.
      When is Torii Pharmaceutical Co ’s upcoming earnings report date?
      Torii Pharmaceutical Co ’s upcoming earnings report date is Feb 06, 2025 which is in 18 days.
        How were Torii Pharmaceutical Co ’s earnings last quarter?
        Currently, no data Available
        Is Torii Pharmaceutical Co overvalued?
        According to Wall Street analysts Torii Pharmaceutical Co ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Torii Pharmaceutical Co pay dividends?
          Torii Pharmaceutical Co does not currently pay dividends.
          What is Torii Pharmaceutical Co ’s EPS estimate?
          Torii Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Torii Pharmaceutical Co have?
          Torii Pharmaceutical Co has 28,800,000 shares outstanding.
            What happened to Torii Pharmaceutical Co ’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Torii Pharmaceutical Co ?
            Currently, no hedge funds are holding shares in TRXPF
            ---

            Company Description

            Torii Pharmaceutical Co

            Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Takeda Pharmaceutical Co
            Astellas Pharma
            Chugai Pharmaceutical Co
            Eisai Co
            Daiichi Sankyo Company
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis